Growth Platform Relevate has a strategic mandate to build a leading healthcare commercialization platform, backed by its partnership with Mountaingate Capital. This creates potential demand for sales enablement, customer data, analytics, and scalable marketing technology that supports growth across pharmaceutical, biotech, and medical device clients.
Acquisition Integration The 2024 acquisition of Level Ex’s pharma and life sciences division expanded Relevate’s medical gaming capabilities and customer reach. Business development teams can explore opportunities around integrating platforms and operations, cross selling services, and supporting continued product development.
Digital Engagement Relevate develops interactive medical education games intended to improve clinician proficiency and patient outcomes. Its 2026 Pivot module partnership and diabetes game highlight opportunities for partners offering app engagement, patient education, adherence programs, and measurement of learning or health outcomes.
AI Visibility Relevate has demonstrated interest in making brand content more discoverable in AI Overviews. This signals potential demand for AI search optimization, content strategy, and tools that help pharmaceutical clients improve visibility and assess performance in emerging search experiences.
Technology Scale With 51 to 200 employees, reported revenue of $10 million to $25 million, and a technology stack spanning AWS, Salesforce, GitHub, and Vercel, Relevate may benefit from solutions that improve cloud efficiency, CRM workflows, software delivery, and coordination across its growing portfolio.